News

10/20/2016 Agilent Technologies Launches SureGuide CRISPR Libraries for Functional Genomics

SureGuide Offerings Include GeCKO Libraries and Full Customization for Any CRISPR Screening Experiment SANTA CLARA, Calif., Oct. 20, 2016 Agilent Technologies Inc. (NYSE: A) today launched a compreh ... More

09/29/2016 Agilent Technologies and Burning Rock Sign Agreement on Molecular Diagnostics

Companies Collaborate in Their Aim to Accelerate Accurate Diagnosis SANTA CLARA, Calif., and GUANGZHOU, China, Sept. 29, 2016 Agilent Technologies Inc. (NYSE: A) and Burning Rock today announced they ... More

09/22/2016 Agilent Technologies Launches New Panel for Fast FISH Testing

New Lung Cancer Panel Enables Acceleration of Routine, Automated Testing in Pathology Laboratories SANTA CLARA, Calif., Sept. 22, 2016 Agilent Technologies Inc. (NYSE: A) today announced the EU launc ... More

08/03/2016 Agilent Technologies Announces Availability of New Companion Diagnostic in Europe

Validated Assay Offers New Option for Lung Cancer Patients CARPINTERIA, Calif., Aug. 3, 2016 Dako, Agilent Pathology Solutions, a worldwide leader in partnering with pharmaceutical companies to devel ... More

07/28/2016 Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research

SANTA CLARA, Calif., July 28, 2016 Agilent Technologies Inc. (NYSE: A) today announced that scientists using the company's comparative genomic hybridization (CGH) technology have shown that cancer ce ... More

05/11/2016 Dako, an Agilent Technologies Company, Announces Expanded Use of PD-L1 Diagnostic Test in Europe

CARPINTERIA, Calif., May 11, 2016 Dako, Agilent Pathology Solutions, a worldwide leader in partnering with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy ... More

04/07/2016 Agilent Technologies and Applied Spectral Imaging Announce Co-Marketing Agreement for Fluorescence In Situ Hybridization

SANTA CLARA and CARLSBAD, Calif., April 7, 2016 Agilent Technologies Inc. (NYSE: A) and Applied Spectral Imaging (ASI) today announced they have entered into an agreement to jointly market ASI's most ... More

04/06/2016 Dako, an Agilent Technologies Company, Announces Availability of New Lung Cancer Test in Europe

In Vitro Diagnostic Approved to Support Use of Bristol-Myers Squibb's OPDIVO® for Non-Squamous Non-Small Cell Lung Cancer CARPINTERIA, Calif., April 6, 2016 Dako, an Agilent Technologies company ... More

03/10/2016 Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma

CARPINTERIA, Calif., Jan. 25, 2016 Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has approve ... More